Vascular Biogenics Ltd (VBLT): Due Diligence on the short case for VBLT...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Vascular Biogenics Ltd (VBLT)

Reply Private New

Keep Last Read

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Followers	8
Posts	2018
Boards Moderated	0
Alias Born	07/19/2006

Re: davidal66 post# 396

Saturday, 07/23/2016 12:22:58 AM

Saturday, July 23, 2016 12:22:58 AM

Due Diligence on the short case for VBLT and my response: Part four.

A final point and question to the board.

Yes, biotech's can be sketchy and shady. But would Harvard simply fudge data or massage it to please VBLT. Is the reputation of Harvard scientists really so important that they want to please VBLT's management? It's not like VBLT really has anything to offer a Harvard oncologist. Maybe AMGN or Biogen or AZN, but VBLT? That's not an argument that VB-111 works and the skeptics are wrong; it's just that Harvard has nothing to gain from ginning up/massaging/fudging data to please an Israeli micro cap running on fumes. The same can be said for the KOL talk on glioblastoma a few months ago; does a top drawer neuro oncologist really care to talk up VB-111 just to please a rinky-dink biotech?

Question to the board. I would love some feedback on my thoughts on the short thesis for VB-111. Where is my analysis right or wrong. Thanks and have a great weekend. david

Keep Last Read

Replies (2) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent VBLT News

Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 04/19/2024 08:56:08 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/12/2024 12:44:49 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 04/11/2024 09:00:40 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/09/2024 09:20:13 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/08/2024 04:15:14 PM
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 04/01/2024 08:30:38 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2024 01:00:14 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 01:15:22 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 02/16/2024 02:00:13 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/05/2024 10:00:08 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 09:05:36 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 04:05:45 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 04:05:20 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 04:04:43 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 04:04:24 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 04:02:17 PM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/11/2024 10:22:04 PM
Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 01/08/2024 09:21:10 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 10:00:38 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 10:00:22 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/28/2023 10:00:21 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/26/2023 10:00:09 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2023 01:15:18 PM
Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/29/2023 10:15:27 PM

More VBLT News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow